REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients

BACKGROUND: Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for national health services and reduce the risk of serious infection. However, there is little information about whether such a decis...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Álvaro, Isidoro, Blasco, Antonio J., Lázaro, Pablo, Sánchez-Piedra, Carlos, Almodovar, Raquel, Bachiller-Corral, Javier, Balsa, Alejandro, Caliz, Rafael, Candelas, Gloria, Fernández-Carballido, Cristina, García-Aparicio, Angel, García-Magallón, Blanca, García-Vicuña, Rosario, Gómez-Centeno, Antonio, Ortiz, Ana M., Sanmartí, Raimon, Sanz, Jesús, Tejera, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727544/
https://www.ncbi.nlm.nih.gov/pubmed/29264411
http://dx.doi.org/10.1016/j.heliyon.2017.e00452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727544/
https://www.ncbi.nlm.nih.gov/pubmed/29264411
http://dx.doi.org/10.1016/j.heliyon.2017.e00452

Ejemplares similares